Breaking News
7 minutes ago
Simantini Singh Deo
Mesoblast receives FDA IND clearance for registrational trial of Ryoncil in Duchenne muscular dystrophy and partners with PPMD to support patient enrollment and study execution.
Simantini Singh Deo
PathAI partners with MedStar Health to deploy AISight Dx digital pathology platform and AI algorithms across its network, enhancing diagnostic accuracy, workflow efficiency, and collaboration.
Simantini Singh Deo
Sanofi reports positive Phase 2 results for lunsekimig in asthma and chronic respiratory diseases, showing reduced exacerbations, improved lung function, and consistent safety profile.
Simantini Singh Deo
Merakris Therapeutics reports positive Phase II and real-world data for MTX-001 in venous leg ulcers, showing ulcer size reduction and supporting progression toward late-stage clinical trials.
Simantini Singh Deo